HIKAL
Back to Balance Sheet
|
HIKAL Last 5 Year Capital Work in Progress History
[Consolidated]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Capital Work in Progress | ₹121 Cr | ₹414 Cr | ₹402 Cr | ₹285 Cr | ₹245 Cr |
What is the latest Capital Work in Progress ratio of HIKAL ?
| Year | Capital Work in Progress |
|---|---|
| Mar2025 | ₹121 Cr |
| Mar2024 | ₹414 Cr |
| Mar2023 | ₹402 Cr |
| Mar2022 | ₹285 Cr |
| Mar2021 | ₹245 Cr |
How is Capital Work in Progress of HIKAL Trending?
| Years | Capital Work in Progress | % Change | |
|---|---|---|---|
| Mar2025 | ₹121 Cr | -70.75 | |
| Mar2024 | ₹414 Cr | 3.04 | |
| Mar2023 | ₹402 Cr | 40.99 | |
| Mar2022 | ₹285 Cr | 16.22 | |
| Mar2021 | ₹245 Cr | - | |
Compare Capital Work in Progress of peers of HIKAL
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| HIKAL | ₹2,369.2 Cr | 7.1% | 11.5% | -50.9% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹401,937.0 Cr | 1.2% | -7% | 2.5% | Stock Analytics | |
| DIVIS LABORATORIES | ₹165,359.0 Cr | 1.8% | 2.7% | 17% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹141,431.0 Cr | 0.5% | -4.8% | 32.9% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹103,114.0 Cr | 0.3% | -4.5% | 11.5% | Stock Analytics | |
| CIPLA | ₹100,028.0 Cr | 0.7% | -5.8% | -13.1% | Stock Analytics | |
HIKAL Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| HIKAL | 7.1% |
11.5% |
-50.9% |
| SENSEX | 2.4% |
3.2% |
5.8% |
You may also like the below Video Courses